Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. | CEO and President, Director | Common Stock | 146K | $123K | $0.84 | Aug 16, 2024 | Direct |
Seres Therapeutics, Inc. | CEO and President, Director | Restricted Stock Units | 78.1K | $65.6K | $0.84 | Aug 15, 2024 | Direct |
Seres Therapeutics, Inc. | CEO and President, Director | Stock Option (Right to Buy) | 823K | Feb 14, 2024 | Direct | ||
Sigilon Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | $6.64 | Aug 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | Aug 15, 2024 | 3 | -$2.12K | 4 | Aug 19, 2024 | CEO and President, Director |
MCRB | Seres Therapeutics, Inc. | May 15, 2024 | 3 | -$2.29K | 4 | May 17, 2024 | CEO and President, Director |
MCRB | Seres Therapeutics, Inc. | Feb 14, 2024 | 6 | -$12.5K | 4 | Feb 16, 2024 | CEO and President, Director |
MCRB | Seres Therapeutics, Inc. | Oct 27, 2023 | 4 | -$11.5K | 4 | Oct 31, 2023 | CEO and President, Director |
SGTX | Sigilon Therapeutics, Inc. | Aug 11, 2023 | 2 | -$7.95K | 4 | Aug 11, 2023 | Director |
SGTX | Sigilon Therapeutics, Inc. | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
MCRB | Seres Therapeutics, Inc. | Feb 3, 2023 | 2 | $0 | 4 | Feb 7, 2023 | CEO and President, Director |
MCRB | Seres Therapeutics, Inc. | Jul 5, 2022 | 1 | $200K | 4 | Jul 6, 2022 | CEO and President, Director |
SGTX | Sigilon Therapeutics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
MCRB | Seres Therapeutics, Inc. | Feb 4, 2022 | 1 | $0 | 4 | Feb 8, 2022 | President, CEO, Director |
SGTX | Sigilon Therapeutics, Inc. | Jun 24, 2021 | 1 | $88.6K | 4 | Jun 28, 2021 | Director |